ALR Technologies SG (ALRTF) Consolidated Net Income (2024 - 2025)

ALR Technologies SG posted quarterly Consolidated Net Income of -$620706.0 for Q2 2025, up 23.68% year-on-year from -$501850.4 in Q2 2024, and up 23.68% on a QoQ basis from -$813331.0 in Q2 2024.

ALR Technologies SG (ALRTF) has 2 years of Consolidated Net Income data on file, last reported at -$620706.0 in Q2 2025.

  • For the quarter ending Q2 2025, Consolidated Net Income rose 23.68% year-over-year to -$620706.0; the trailing twelve-month figure through Dec 2025 stood at -$1.4 million (down 76.32% YoY), and the FY2025 full-year result was -$2.9 million, up 15.55% from the prior year.
  • Consolidated Net Income for Q2 2025 stood at -$620706.0, up from -$813331.0 in the prior quarter.
  • Across five years, Consolidated Net Income topped out at -$620706.0 in Q2 2025 and bottomed at -$813331.0 in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.08 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 745.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 273.95 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 199.50 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 411.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 ALR Technologies SG - - - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 -620,706.00
Jun 30, 2024 -813,331.00